Fierce Biotech
Fierce Biotech Fundraising Tracker ’26: Immutrin’s $87M series A; Crossbow targets $77M
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.